These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11495085)

  • 1. Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C.
    Firneisz G; Lakatos PL; Szalay F;
    Scand J Gastroenterol; 2001 Aug; 36(8):877-80. PubMed ID: 11495085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis.
    Lakatos PL; Firneisz G; Borcsiczky D; Zalatnai A; Selmeci L; Szalay F
    Eur J Clin Invest; 2000 Sep; 30(9):793-7. PubMed ID: 10998079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
    Maes M; Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Meltzer H
    Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections.
    Andrieu T; Thibault V; Malet I; Laporte J; Bauvois B; Agut H; Cahour A
    J Clin Virol; 2003 May; 27(1):59-68. PubMed ID: 12727530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders.
    Hildebrandt M; Rose M; Mayr C; Arck P; Schüler C; Reutter W; Salama A; Klapp BF
    Adv Exp Med Biol; 2000; 477():197-204. PubMed ID: 10849747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.
    Yang SS; Fu LS; Chang CS; Yeh HZ; Chen GH; Kao JH
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1789-93. PubMed ID: 17074015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
    Cuchacovich M; Gatica H; Pizzo SV; Gonzalez-Gronow M
    Clin Exp Rheumatol; 2001; 19(6):673-80. PubMed ID: 11791639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.
    Yıldırım FE; Karaduman A; Pinar A; Aksoy Y
    Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders.
    Hildebrandt M; Rose M; Mayr C; Schüler C; Reutter W; Salama A; Klapp BF
    Scand J Immunol; 1999 Nov; 50(5):536-41. PubMed ID: 10564557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.
    Buljevic S; Detel D; Pucar LB; Mihelic R; Madarevic T; Sestan B; Varljen J
    Rheumatol Int; 2013 Nov; 33(11):2867-74. PubMed ID: 23864142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
    Ruiz P; Zacharievich N; Shenkin M
    Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
    Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
    Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eating disorders: a role for dipeptidyl peptidase IV in nutritional control.
    Hildebrandt M; Rose M; Mönnikes H; Reutter W; Keller W; Klapp BF
    Nutrition; 2001 Jun; 17(6):451-4. PubMed ID: 11399402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence.
    Perner F; Gyuris T; Rákóczy G; Sárváry E; Görög D; Szalay F; Kunos I; Szönyi L; Péterfy M; Takács L
    J Lab Clin Med; 1999 Jul; 134(1):56-67. PubMed ID: 10402060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.
    Korom S; De Meester I; Stadlbauer TH; Chandraker A; Schaub M; Sayegh MH; Belyaev A; Haemers A; Scharpé S; Kupiec-Weglinski JW
    Transplantation; 1997 May; 63(10):1495-500. PubMed ID: 9175816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin.
    Lee S; Macquillan GC; Keane NM; Flexman J; Jeffrey GP; French MA; Brochier J; Price P
    Immunol Cell Biol; 2002 Aug; 80(4):391-7. PubMed ID: 12121229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
    Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
    Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
    Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
    Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD26/DPP IV in experimental and clinical organ transplantation.
    Korom S; de Meester I; Belyaev A; Schmidbauer G; Schwemmle K
    Adv Exp Med Biol; 2003; 524():133-43. PubMed ID: 12675233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.